Synopsis of recent research by authors named "Bowu Chen"
- Bowu Chen's recent research primarily focuses on evaluating the efficacy and safety of traditional Chinese medicine (TCM) formulations, such as Huashi Baidu granule and Jingyin granules, in treating various stages of COVID-19 among high-risk patients and those with mild symptoms.
- Chen's studies reveal promising findings, indicating that TCM formulas may provide therapeutic benefits in managing COVID-19, potentially improving patient outcomes in mild cases and offering alternative treatment strategies for severe infections.
- Additionally, his research extends to investigating the protective effects of ancient herbal formulas on liver diseases, highlighting the multifaceted applications of TCM in both respiratory and hepatic health conditions.
